American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…
Read More »Obesity
Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals…
Read More »
When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…
Read More »
The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…
Read More »
A new study has pinpointed brain neurons that separate the sensation of fullness from nausea in obesity drugs, paving the…
Read More »
Recent research from the University of Colorado Boulder suggests that consuming a high-fat diet can negatively impact gut bacteria and…
Read More »
A recent study has identified specific gut bacteria linked to food addiction and potential protective effects, offering new insights into…
Read More »
A study by Johns Hopkins Medicine and NIH’s National Institute on Aging on 40 older adults with obesity and insulin…
Read More »
A new study demonstrates tirzepatide, a drug originally used for diabetes, significantly reduces obstructive sleep apnea symptoms in obese individuals.…
Read More »
Systematic reviews from 2020 to 2024 indicate that bariatric surgery provides the most sustained and substantial weight loss compared to…
Read More »